With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...
Every minute, 38 people are diagnosed with cancer, and 18 people die from it globally, according to the World Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback